Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Death Receptor for Granzyme B during Cytotoxic T Cell–Induced Apoptosis  by Motyka, Bruce et al.
Cell, Vol. 103, 491–500, October 27, 2000, Copyright ª 2000 by Cell Press
Mannose 6-Phosphate/Insulin-like Growth Factor II
Receptor Is a Death Receptor for Granzyme B
during Cytotoxic T Cell–Induced Apoptosis
purified and identified (Shi et al., 1992a, 1992b) as a
known cytotoxic cell protease (CCP1) (Lobe et al., 1986),
now referred to as granzyme B (grB) (Masson and
Tschopp, 1987). In a complementary approach, it was
shown that cells were endowed with the ability to induce
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Canada through which granzyme could pass. Once the protein-
ase is inside the target cell cytoplasm the apoptotic
program is initiated through the activation of caspases,
Summary the cysteine proteases responsible for execution of the
cell death pathway (reviewed in Wolf and Green, 1999).
The serine proteinase granzyme B is crucial for the Initially it was shown in vitro that caspase 3 was a sub-
rapid induction of target cell apoptosis by cytotoxic T strate for grB (Darmon et al., 1995; Martin et al., 1996)
cells. Granzyme B was recently demonstrated to enter and now similar results have been observed for a large
cells in a perforin-independent manner, thus pre- number of the caspases (Darmon and Bleackley, 1998).
dicting the existence of a cell surface receptor(s). We The perforin channel model has been widely ac-
now present evidence that this receptor is the cation- cepted, although there is very little experimental evi-
independent mannose 6-phosphate/insulin-like growth
dence to prove polyperforin can transport a macromole-
factor receptor (CI-MPR). Inhibition of the granzyme
cule of z30 kDa such as grB (Browne et al., 1999).
B–CI-MPR interaction prevented granzyme B cell sur-
Replication-deficient adenovirus (AD) can substitute for
face binding, uptake, and the induction of apoptosis.
perforin and was reported to facilitate uptake of grBSignificantly, expression of the CI-MPR was essential
and induce apoptosis (Froelich et al., 1996). Subsequentfor cytotoxic T cell-mediated apoptosis of target cells
studies indicated that grB uptake occurs independentlyin vitro and for the rejection of allogeneic cells in vivo.
of AD (Shi et al., 1997; Pinkoski et al., 1998). Cells withThese results suggest a novel target for immunother-
internalized grB showed no morphological signs or bio-apy and a potential mechanism used by tumors for
chemical markers of apoptosis until they were subse-immune evasion.
quently treated with perforin or AD. We hypothesized
that grB was taken up by receptor-mediated endocyto-Introduction
sis and required perforin or AD to mediate its release
into the cytoplasm and hence gain access to criticalTwo mechanisms have been proposed for the induction
substrates such as the caspases.of apoptosis in virus-infected and tumor cells by cyto-
A fundamental prediction from our model is the exis-toxic T cells (CTL; reviewed by Shresta et al., 1998). The
tence of a cell surface receptor that can bind and inter-first involves granule-mediated exocytosis of cytolytic
nalize grB. Here we report the identity of this receptormolecules, while the second relies on an interaction
and demonstrate its importance in apoptosis mediatedbetween Fas ligand expressed on the CTL with Fas
by granule-purified grB or by CTL.receptor on the surface of the target.
The granule-exocytosis model has evolved since its
original enunciation by Henkart (Henkart, 1985). Initially
Resultsone of the granule proteins, perforin, was thought to be
the major effector of CTL-induced death. However, it
Phosphorylation of GrB Is Required for Cellthen became apparent that target cells were dying
Surface Binding and Apoptosis Inductionthrough an apoptotic mechanism that involved damage
In our search to characterize a receptor for grB, weof DNA (Duke et al., 1989). The factor responsible was
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and that was inhibitable with unlabeled grB. Using la-
beled grB, we tested the ability of a number of factors
and conditions to modulate this binding. Our approach
was guided by the surprising finding that recombinant
grB was not as biologically active as purified granule-
derived grB, although they were comparable in enzy-
matic activity (data not shown). One possibility that
could explain this discrepancy would be a difference in
the post-translational processing of grB.
In order to test the importance of phosphorylation
Jurkat cells were incubated at 48C with grB-biotin that
had been treated at 378C with alkaline phosphatase in
phosphate-free buffer. As a control, grB was treated
without phosphatase, or with phosphatase in a phos-
phate-containing buffer to inhibit phosphatase activity
(Lakshmi and Balasubramanian, 1980). Treatment of grB
with phosphatase in a phosphate-free buffer had no
effect on the enzymatic activity of grB, but did result in
a marked reduction in its ability to bind Jurkat cells
(Figure 1A).
If the internalization of grB by receptor-mediated en-
docytosis is necessary for apoptosis, then grB that does
not bind to the cell surface should be ineffective in killing.
To test this, Jurkat cells were incubated for 3 hr with
phosphatase-treated grB and AD and analyzed using a
TUNEL or annexin V assay. Less than 5% of cells were
TUNEL positive after incubation with dephosphorylated
grB (Figure 1B) compared with 50% TUNEL positive
cells after treatment with grB pretreated with alkaline
phosphatase in phosphate-containing buffer. Similar re-
sults were observed using annexin V as a marker for
apoptotic cells (Figure 1B). In order to distinguish
whether these results were due to the dephosphor-
ylation of carbohydrate or of amino acid moieties, grB
was treated with the 37 kDa catalytic subunit of re-
combinant protein phosphatase-1 (a serine/threonine/
tyrosine phosphatase) under conditions where other
proteins are effectively dephosphorylated (Bagu et al.,
1997). We found that grB did not lose enzymatic activity
or its ability to bind and to induce apoptosis of Jurkat
cells (data not shown), and thus we conclude that phos-
phorylation of carbohydrate is important.
Figure 1. Phosphatase Treatment of grB Inhibits Its Ability to Bind
at the Cell Surface and to Mediate Apoptosis
(A) Flow cytometric analysis of the binding of grB-biotin to Jurkat
cells after prior treatment of the proteinase at 378C for 60 min with
or without alkaline phosphatase (AP) in the presence or absence of
phosphate buffer (PO4) as described in Experimental Procedures.
The percentage of positive staining cells (region markers not shown
in three-dimensional histogram) and the relative mean fluorescence
intensity (MFI), shown in brackets, are indicated. Relative cell num-
ber is represented on the y axis.
(B) DNA fragmentation and phosphatidylserine externalization as
assessed by TUNEL and annexin V labeling, respectively, after a 3
hr treatment at 378C of Jurkat cells with 10 pfu/cell replication-
deficient AD and 100 ng/ml grB that was or was not pretreated
with alkaline phosphatase as outlined above. The percent specific
positive labeling cells was determined by flow cytometric analysis
as outlined in Experimental Procedures. The percentage of TUNEL/
annexin V positive cells incubated without treatment or with only
grB was under 8%. Data shown in (A) is representative of at least
three experiments. Data shown in (B) is the mean 6 SD of three
experiments.
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GrB Binds to the MPR to Induce Apoptosis
Two types of mannose 6-phosphate receptors (MPR)
have been described, the z270 kDa cation-independent
MPR (CI-MPR) also known as the insulin-like growth
factor receptor (IGF-IIR), and the 46 kDa cation-depen-
dent MPR (CD-MPR) (reviewed in Kornfeld, 1992; Dahms,
1996; Munier-Lehmann et al., 1996). Both are type I gly-
coproteins that have a high binding affinity for lysosomal
enzymes and other proteins that contain phosphoman-
nosyl residues. Using wild-type L cells and L cells that
were either deficient in the expression of CI-MPR (MPR–
cells), or that were transfected to overexpress the CI-
MPR (CI-MPR1 cells) or the CD-MPR (CD-MPR1 cells)
(Gabel et al., 1983; Watanabe et al., 1990), we found a
direct correlation between cell surface MPR expression
and grB binding (Figure 2A). In addition, in agreement
with the results obtained with Jurkat cells, treatment of
grB with alkaline phosphatase in the absence of phos-
phate resulted in a dramatic decrease in binding to L
cells and the MPR-transfected L cell lines. Furthermore,
by confocal analysis of CI-MPR1 cells after incubation
with grB-OG at 378C, we observed intracellular localiza-
tion of grB that was treated with alkaline phosphatase
in the presence of phosphate, but not with grB that was
dephosphorylated (data not shown).
The L cell series was then tested for susceptibility
to killing by grB and AD. The MPR– line was relatively
resistant to grB and AD-induced DNA fragmentation
(Figure 2B). Conversely, the CI-MPR1 and wild-type L
cells underwent DNA fragmentation and bound annexin
V after treatment (Figure 2B). At the time-point of the
assay about 30% of the CI-MPR1 and L cells were
TUNEL and annexin V positive, however at later times
this number approached 100% (data not shown). In stark
contrast the CD-MPR1 line was resistant to grB and AD-
mediated DNA fragmentation and did not bind annexin
V (Figure 2B).
Inhibition of GrB Binding and Uptake by M6P
The binding and uptake of acid hydrolases by the MPR
is blocked by mannose 6-phosphate (M6P) (Kaplan et
al., 1977). Cells were treated at 48C with various concen-
trations of M6P together with labeled grB and analyzed
by flow cytometry. At a concentration of 20 mM, M6P
considerably reduced binding of grB to Jurkat cells with
Figure 2. GrB Binds to Both the CI- and the CD-MPR but It Is the
Expression of the CI-MPR that Is Required for grB-Mediated Apo-
ptosis
(A) The binding of grB was compared with the level of expression
of cell surface MPR using antisera specific for the CI- and CD- forms
of the MPR. Wild-type L-cells and the L(Rec–) cell series (MPR–-, CI-
MPR1-, and CD-MPR1-cells) were treated as described above with
grB-OG or with anti-MPR. All labeling steps were carried out at 48C.
Data is presented as the relative MFI as described in Experimental
Procedures.
(B) TUNEL and annexin V labeling of L cells and the L(Rec–) cell
series after a 3 hr incubation with 100 ng/ml grB and AD. The percent
specific positive labeling cells was determined by flow cytometric
analysis. Data shown in (A) is representative of at least three experi-
ments. Data shown in (B) is the mean 6 SD of at least three experi-
ments.
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Figure 3. M6P Inhibits GrB Binding, Uptake
and Apoptosis Induction
(A) GrB-OG binding to CI-MPR1 cells in the
presence or absence of M6P or D-mannose
at different concentrations, or with 50 mM
D-glucose or D-glucose-6 phosphate. Cells
were labeled and incubated as previously de-
scribed. Maximal binding was taken as the
MFI of grB-OG binding to CI-MPR1 cells in
the absence of monosaccharide.
(B) Confocal analysis of CI-MPR1 cells incu-
bated with grB-OG in the presence or ab-
sence of M6P. Cells were incubated for 20
min at 378C without grB-OG (a), or with
grB-OG either in the absence (b), or presence
of 20 mM M6P (c).
(C) Jurkat cells were incubated for 3 hr with
different concentrations of grB and AD fol-
lowing a 15 min incubation with different con-
centrations of M6P or related monosaccha-
rides. Cells were then labeled using a TUNEL
or annexin V assay and analyzed by flow cy-
tometry. The percentage of TUNEL/annexin
V positive cells after incubation with grB and
AD with either 25 mM D-glucose 6-phos-
phate, D-mannose, or D-glucose was 60/41,
52/32, and 66/40, respectively. Data shown
in (A-C) is representative of at least three ex-
periments.
half-maximal inhibition occurring at a concentration of To examine this, Jurkat cells were treated with or with-
1 mM M6P (Figure 3A). Mannose and glucose had no out M6P or other sugars along with grB and AD for
effect on grB binding, whereas glucose 6-phosphate 3 hr, and analyzed for apoptosis (Figure 3C). Signifi-
had a slight inhibitory effect that was only evident at cantly, we found that 200 mM or greater of M6P markedly
concentrations above 25 mM (Figure 3A). Similar results reduced in a dose-dependent manner the percentage
were observed with the wild-type L cells, or with the CI- of TUNEL or annexin V positive cells (Figure 3C). In
MPR1 and CD-MPR1 cells (data not shown). contrast, treatment with other related sugars or sugar
Finally, the effect of M6P on the uptake of grB was phosphates had little effect on grB-mediated apoptosis
assessed. CI-MPR1 cells were incubated at 378C with (Figure 3C). Similar results were seen with L cells and
grB-OG with or without 20 mM M6P and analyzed by CI-MPR1 cells. No effect of M6P was observed on infec-
confocal microscopy. In the presence of M6P essentially tion of AD containing a b-galactosidase insert. Finally,
no grB could be detected within the cells (Figure 3B). using Jurkat cells, we found that the preincubation of
grB with soluble CI-MPR ($100 mg/ml) markedly re-
duced in a dose-dependent manner both the cell surfaceInhibition of GrB/AD-Mediated Apoptosis by M6P
binding of grB, and grB/AD-mediated apoptosis (dataA critical question was whether the grB-MPR interaction
at the cell surface correlated with grB biological activity. not shown).
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Correlation of CTL-Mediated Target Cell Apoptosis
with Cell Surface CI-MPR Expression
The results presented thus far implicate an essential
role for the CI-MPR in the binding and uptake of grB in
vitro. However, it was essential to determine the impor-
tance of the CI-MPR in CTL-mediated killing, and thus
we used MPR– and CI-MPR1 cells as targets with a CTL
line at various effector:target ratios. The extent of target
cell DNA fragmentation was assessed by 3H-thymidine
release after 3 hr and membrane damage by 51Cr-release
after 5 hr. CTL-mediated apoptotic death of targets
within the first 3 hr is mediated by grB whereas granzyme
A (grA)- and Fas-mediated killing are detected at later
times (Shresta et al., 1998). Incubation of effectors and
targets in the presence of a blocking anti-Fas mono-
clonal antibody (mAb) had no effect on DNA fragmenta-
tion or 51Cr-release, indicating that killing within this time
period was Fas-independent. This mAb abrogated DNA
fragmentation of these target cells by a perforin-defi-
cient murine CTL line after a 4-hr incubation (data not
shown). After incubation with CTL, the MPR– target cells
showed a low amount of DNA fragmentation but a signifi-
cant amount of 51Cr-release which increased with the
effector:target (E:T) cell ratio (Figure 4). However, in
comparison there was much greater DNA fragmentation
with CI-MPR1 target cells, although the extent of 51Cr-
release was similar to that of MPR– cells (Figure 4).
We attempted to assess the importance of the MPR
in CTL-mediated killing by incubating the effectors with
targets in the presence of M6P. However, half-maximal
inhibition of target cell DNA fragmentation was only evi-
dent with M6P at unphysiological concentrations (. 25
mM) (data not shown).
Figure 4. Correlation of CTL-Mediated Target Cell DNA Fragmenta-
tion with CI-MPR Expression
Transplant Rejection Proceeds Through A human CTL line was incubated with either CI-MPR1 or MPR– target
the CI-MPR cells at E:T ratios of 4:1, 2:1, and 1:1. The percent specific
3H-thymidine-release (measure of DNA fragmentation) and 51Cr-The in vivo significance of our results was evaluated
release (measure of outer-membrane damage) of the target cellsusing transplantation of allogeneic cells. Cells were
was determined after a 3- and 5-hr incubation, respectively. Datatransplanted under the kidney capsule since this has
is the mean 6 SD of three experiments.
been shown to be a suitable anatomical space to main-
tain the survival of cellular grafts such as pancreatic
islets (Diamond and Gill, 2000) and hepatocytes (Ohashi but the MPR– cells survived despite the significant infil-
et al., 2000). Furthermore, since this site maintains trate. Parental wild-type L cells were also rejected with
the cells in close proximity to each other, it is also use- similar kinetics (data not shown).
ful for determining the degree of graft rejection as
well as assessing the phenotypes of cellular infilitrates.
By microinjection, donor H-2k-expressing MPR– or CI- Discussion
MPR1 cells were transplanted under the kidney capsule
of BALB/c-recipients (H-2d). Graft cell survival was moni- GrB Binding and Uptake by the Cell Surface MPR
The CI- and CD-MPR are found predominantly insidetored after 7 and 14 days by immunostaining kidney
capsule tissue with mAb specific for H-2Kk, CD4, and the cell where they play key roles in targeting M6P-
expressing proteins from the Golgi to a pre-lysosomalCD8. As a control, donor cells were also transplanted
in SCID hosts and monitored in the same way. The re- compartment (Griffiths et al., 1990). Both receptors are
also present at the cell surface, although the CI-MPR issults of the transplant into BALB/c recipients were clear:
at day 7 the CI-MPR-expressing donor cells were com- thought to be the predominant receptor for the binding
and uptake of M6P-containing molecules (Stein et al.,pletely rejected, whereas at day 14 CI-MPR-deficient
donor cells remained in the kidney capsule where they 1987; Ma et al., 1991). We found that granule-purified
grB bound at negligible levels to cells deficient in CI-appeared to have expanded (Figure 5). In the lympho-
cyte-deficient SCID host, both MPR– and CI-MPR1 cells MPR expression, but at high levels to CI-MPR deficient
cells transfected to overexpress the CI-MPR or the CD-survived the engraftment (Figure 5). CD41 and CD81
cells were present in the BALB/c kidney capsule indicat- MPR (Figure 2A). The dephosphorylation of grB mark-
edly prevented its binding (Figure 1A) and uptake (dataing lymphocyte infiltration with both cell lines. In the
case of CI-MPR1 cells, this appeared to lead to rejection, not shown), as did coincubation with M6P (Figure 3A)
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Figure 5. Correlation of CI-MPR Expression with Allograft Survival
CI-MPR1 and MPR– cells (H-2k-expressing) were used as donor cells for transplantation under the kidney capsule of allogeneic recipient
BALB/c or SCID mice. Mice were sacrificed after 7- or 14-days and immunohistochemical labeling of the kidney capsule was performed using
mAb specific for H-2k, CD4, or CD8 as described in Experimental Procedures. Bars correspond to 10 mm. Data shown is representative of
three experiments.
or soluble CI-MPR (data not shown). Taken together, 1989), leukemia inhibitory factor (Blanchard et al., 1998),
and the Herpes simplex virus (Brunetti et al., 1994).these findings support a model whereby grB binding
and uptake involves an interaction with cell surface MPR
that is dependent on the expression of the M6P recogni- Interaction of GrB with the CI-MPR Is Critical
for Apoptosistion marker on grB.
The CI-MPR and CD-MPR are usually thought of as The extent of grB-mediated apoptosis was much greater
for CI-MPR1 cells compared with MPR– cells (Figure 2B),being important in the trafficking of acid hydrolases to
lysosomes (Nolan and Sly, 1987). Griffiths and Isaaz and apoptosis was inhibited by the coincubation of grB
with M6P (Figure 3C), soluble CI-MPR (sCI-MPR) (data(1993) demonstrated that grA is phosphorylated on high-
mannose residues, and that this modification is impor- not shown), or by the prior treatment of grB with phos-
phatase (Figure 1B). Importantly, there was a direct cor-tant in the intracellular targeting of the granzyme to the
cytolytic granules. It was also suggested that grB may relation between binding and uptake of grB and apopto-
sis (Figure 3A, 3B and 3C). That some apoptosis wasbe similarly phosphorylated (Griffiths and Isaaz, 1993).
Most lysosomal proteins that contain the M6P signal are evident for MPR– cells at high concentrations of grB may
be explained by the very low-level (10% of wild-type)rapidly dephosphorylated once they reach the lysosome
(Einstein and Gabel, 1991), and it might be presumed of endogenous CI-MPR present (Lobel et al., 1989) or
alternatively to limited entry of grB in a non-MPR fashion.that M6P-containing granzyme would also lose its phos-
phates within the cytolytic granules, which have been It is interesting that recombinant forms of grB that
would not be mannose 6-phosphorylated do inducedescribed as secretory lysosomes (Page et al., 1998).
Based on our findings, we suggest that grB possesses apoptosis in vitro (Beresford et al., 1999; Shresta et al.,
1999). However, this grB was only effective in killing atthe M6P modification and that this modification is re-
tained in the cytolytic granule. Retention of the M6P high concentrations. In one study, 5–20 mg/ml of yeast-
derived recombinant grB was required to induce apo-modification may be explained by the observation that
grB is located in the granule core whereas phosphatase ptosis, and this was estimated to be approximately
5–20-fold more than the amount of grB that would beis present in the granule cortex (Page et al., 1998). Neu-
trophil azurphilic granules, which are similar to cytolytic found in all the effector cells in a typical in vitro CTL
assay (Shresta et al., 1999). In comparison we typicallygranules, also contain mannose 6-phosphorylated pro-
teins (Cieutat et al., 1998). used granule-purified grB at concentrations of z50 ng/
ml, and less than 1 ng/ml was sufficient to elicit effectiveAt the cell surface, the CI-MPR is constitutively endo-
cytosed, where its main role is thought to be the binding Jurkat cell killing (Figure 3C). We cannot rule out a minor
MPR-independent pathway, and this may explain theand internalization of the non-glycosylated polypeptide
hormone IGF-II (Oka and Czech, 1986), with a minor role DNA fragmentation seen with CTL acting on MPR– cells
at high E:T ratios. Perhaps a high local concentrationbeing the reuptake of secreted acid hydrolases (Griffiths
et al., 1988; Dahms, 1996). We now suggest that a critical of grB can be achieved at the CTL-target interface such
that some uptake can occur independently of the MPR.function of the CI-MPR is the binding and uptake of grB.
Other non-acid hydrolase proteins besides IGF-II that However, it is clear that this effect is not relevant to the
in vivo rejection model (Figure 5).bind the cell surface CI-MPR include the precursor form
of transforming growth factor-b (pTGF-b) (Kovacina et al., The inability of overexpressed CD-MPR to induce grB-
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mediated apoptosis (Figure 2B) may be due to the ineffi- cently been shown that grB supplemented by grA is
important for graft versus host disease after bone mar-ciency of the CD-MPR to endocytose bound ligand (Mu-
nier-Lehmann et al., 1996). Indeed, we have observed row transplantation (Shresta et al., 1999). That the CI-
MPR- cells survived suggests that delivery of both grAessentially no grB uptake in the CD-MPR-overexpress-
ing CD-MPR1 cells (BM and RCB, unpublished findings). and grB is compromised. This is consistent with the
demonstration of the key role of the MPR in targeting
grA from the trans-Golgi to early endosomes (GriffithsExpression of the CI-MPR Is Critical for
and Isaaz, 1993) and suggests that the same receptorCTL-Mediated Target Cell Apoptosis
acts for both granzymes.In agreement with our model of CI-MPR mediated up-
take of grB, we found that a CTL line efficiently induced
apoptosis in target cells only when the targets ex- Important Implications of the
GrB–CI-MPR Interactionpressed transfected CI-MPR (Figure 4). Similar findings
were obtained with other CTL effectors including acti- The identification of a receptor for grB is significant in
itself, and the discovery carries with it exciting possibili-vated primary splenocytes (BM and RCB, unpublished
findings). Interestingly, it was the DNA fragmentation ties for therapeutic manipulation. However, the revela-
tion that it is the previously described receptor for M6P-component that was effectively prevented in CI-MPR-
deficient targets and not the disruption of the plasma containing glycoproteins and IGF-II has a number of
profound biological implications. For instance, it is inter-membrane. The most likely explanation for this is that
membrane damage is being induced by perforin in the esting that the route of entry into the cell that is used
by some toxins and viruses is the very pathway that willabsence of efficient binding and uptake of grB. Likewise,
the absence of early DNA fragmentation with later 51Cr- cause the demise of the infected cell (Brunetti et al.,
1994; Zhu et al., 1995; Sandvig and Van Deurs, 1996;release has been documented in killing assays that used
grB-deficient CTL (Heusel et al., 1994). Molinari et al., 1997). The MPR has also been implicated
in responses to some growth factors. Of particular noteThe membrane damage observed in cell culture
assays is attributed to perforin but the relevance of this is the internalization and activation via the MPR of
TGF-b, a cytokine that has long been known to act asto in vivo cytotoxicity has recently been questioned
(Shresta et al., 1999). Therefore, we sought to address an immunosuppressive agent (Kovacina et al., 1989).
Perhaps TGF-b also acts in part by blocking the interac-the importance of grB binding and uptake by the CI-
MPR using an in vivo model. We observed that the ex- tion of the receptor with grB and thus inhibiting entry.
Similarly, local expression of other factors such as leu-pression of CI-MPR was critical for the clearance of
transplanted allogeneic cells. Thus cells that were defi- kemia inhibitory factor may impact on responsiveness
to grB.cient in the receptor survived despite the infiltration of
both CD4 and CD8 T cells (Figure 5). In contrast, cells One of the most exciting aspects of the present work
relates to the numerous reports that the CI-MPR recep-transfected to overexpress the receptor (Figure 5) or
wild-type L cells (data not shown) were efficiently re- tor is a tumor suppressor. Loss of heterozygosity has
been reported in a variety of human malignancies includ-jected. Our in vivo data differed from our in vitro findings
in that in the transplantation study the MPR– cells ing hepatocarcinoma (De Souza et al., 1995) and aggres-
sive early breast cancer (Chappell et al., 1997). Further-survived (Figure 5), whereas there was significant 51Cr-
release/lysis of MPR– cells in vitro (Figure 4). This under- more, the CI-MPR locus at 6q has been reported to be
a hot spot for mutation in tumors including malignantscores the questionable relevance of the perforin-medi-
ated 51Cr-release assay compared with what occurs in melanoma (Millikin et al., 1991), ovarian cancer (Foulkes
et al., 1993), non-Hodgkin lymphoma (Gaidano et al.,vivo. Differences in the effective E:T ratios may at least
partially explain the differences between killing in vivo 1992), and renal cell carcinoma (Morita et al., 1991). This
has usually been interpreted on the basis of the CI-MPRand in vitro. Our in vitro data demonstrates the impor-
tance of receptor expression for binding and uptake of regulating responses of cells to IGF-II signaling through
the IGF-IR. However, our data suggest that tumors car-grB but the in vivo result underlines that expression of
CI-MPR is paramount for cell death. rying mutated non-functional CI-MPR would also have
an inherent resistance to the immune system, and thisIn addition to the importance of these studies to define
the mechanism of granule-mediated cytotoxicity, the could play a critical role in the early escape of tumors
and/or metastatic variants from host defenses. In addi-results are also significant for understanding graft rejec-
tion. There has been considerable debate as to the rele- tion, in Wilm’s tumor and rhabdomyosarcomas, IGF-II is
overexpressed and is believed to interfere with signalingvance of antibodies, cytokines, T cell subsets, and mac-
rophages to the rejection process. Undoubtedly these through IGF-IR and the routing of lysosomal proteins
(De Leon et al., 1996). It is also possible that the overex-play an important role but our data strongly suggests
that the granzyme pathway used by CTL is paramount pressed factor could inhibit grB binding and internaliza-
tion. An additional intriguing possibility is the recentat the effector stage. The CI-MPR– cells transplanted
under the kidney were surrounded by CD41 and CD81 observations that sCI-MPR is secreted by breast cancer
lines and also primary metastic breast cancer cells (Con-T cells and are presumably awash in cytokines and anti-
bodies. In addition, it is likely that activated macro- fort et al., 1995). The secreted material could act as a
sink for grB and thus prevent it from acting on the cellphages and their lytic proteins, and Fas ligand positive
cells were present. Despite all this, in the absence of surface receptor. This would create a local immunosup-
pressive environment in a fashion analogous to secretedthe grB receptor, the allogeneic cells survived.
As to the importance of other granzymes, it has re- tumor necrosis factor receptor or Fas ligand. At present,
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for 20 min and washed twice. Unless otherwise indicated, z25 ngthese remain as speculations, but our results provide
grB-biotin or -OG was used to label cells. All steps of the assaythe intellectual framework for the design of experiments
were carried out at 48C to prevent intracellular uptake of grB. PBS/that will enable investigators to test them.
0.1% BSA buffer was used throughout the procedure. In some
In summary, we have demonstrated that the CI-MPR cases, results are presented as the relative MFI, which represents
is a receptor for grB on the target cell surface and that the MFI of the grB-labeled population minus the MFI of the unlabeled
population.this recognition is necessary for the efficient apoptosis
of target cells mediated by granule-purified grB or by
Phosphatase Treatment of GrBCTL. The modulation of the CI-MPR on the target cell
GrB was treated for 1 hr at 378C in a phosphate-free (saline) or asurface would thus have profound repercussions on the
high-phosphate (64.5 mM Na2HPO4·7H2O, 21 mM KH2PO4) bufferability of CTL to induce apoptosis by the grB-mediated with calf intestinal alkaline phosphatase (1–10 U), 20 nM of the 37
pathway. kDa catalytic subunit of recombinant protein phosphatase-1 (Bagu
et al., 1997), or with vehicle control. Cells were then incubated with
Experimental Procedures the treated grB at 48C for 30–60 min. For the TUNEL or annexin V
assays, cells were then washed twice before incubation at 378C
Cell Lines and Reagents with AD.
Murine L cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco) supplemented with 10% FBS and with 2 mM M6P Inhibition Studies
L-glutamine and 100 mg/ml penicillin/streptomycin. The CD-MPR1 M6P and various other monosaccharides at different concentrations
(SR2–1) and CI-MPR1 (MS9-II) cells were derived by transfecting were added to cells for 15 min at 48C before the addition of labeled
human CD- or CI-MPR into an L cell line deficient in endogenous grB, or at room temperature before the addition of grB and AD.
CI-MPR (L(Rec–)), while the MPR– (MS) line was derived by transfec-
tion of L(Rec–) cells with vector alone (Gabel et al., 1983; Watanabe GrB Uptake Assay
et al., 1990) and maintained as previously described (Watanabe et Cells on coverslips were incubated for 20 min at 378C with DMEM/
al., 1990). Human CTL and Jurkat cells were isolated and maintained 0.1% BSA containing 25 ng grB-OG that was untreated, mock-
as previously described (Atkinson et al., 1998). Human replication- treated, or alkaline phosphatase-treated, as described above. For
deficient AD type 5 d170–3 and ADLacZ have been described else- the M6P inhibition studies, cells were treated with 20 mM M6P in
where (Bett et al., 1994; Addison et al., 1997). Rabbit antisera with DMEM/0.1% BSA for 10 min at 378C, before the addition of grB-OG,
specificity for the human CI-MPR (Wood et al., 1991) or CD-MPR as above. Cells were then washed twice with PBS/0.1% BSA, fixed
(Ma et al., 1992) have been described. Goat anti-rabbit-FITC was with 2% paraformaldehyde in PBS, and allowed to dry briefly before
obtained from Jackson ImmunoResearch and streptavidin- the coverslips were mounted and examined by confocal micros-
cychrome from PharMingen. Murine specific CD4 (L3T4) and CD8 copy. Imaging was performed with a Zeiss Axiovert 100M LSM510
(53–6.7) mAb were obtained from Cedarlane. Secondary biotinylated laser scan microscope and analyzed using LSM510 software.
Ab for immunohistochemical staining included goat anti-mouse IgG
and goat anti-rat IgG obtained from Cedarlane and Vector, respec- sCI-MPR Inhibition Studies
tively. Anti-Fas (CD95) mAb specific to mouse (Jo2) or human (APO-1) GrB was incubated with sCI-MPR at various concentrations in PBS/
was obtained from PharMingen. Human sCI-MPR has been 0.1% BSA for 30 min at 48C. Subsequently, cells were incubated
described (Valenzano et al., 1995). M6P and other related monosac- with grB/sCI-MPR for 30–60 min at 48C and washed twice, before
charides, as well as calf-intestinal phosphatase were purchased analysis of binding, or before the addition of AD for TUNEL and
from Sigma. The catalytic subunit of protein phosphatase-1 has annexin V analysis.
been described (Bagu et al., 1997).
TUNEL and Annexin V Apoptosis Assays
Purification of GrB and Preparation of Labeled GrB Probe For the in vitro killing assays, 10 pfu per cell of AD were added
Human grB was purified from the cytolytic granules of YT-Indy cells subsequent to grB addition. Analysis of DNA fragmentation by
as described previously (Caputo et al., 1999). grB was derivatized TUNEL analysis has been described previously (Heibein et al., 1999).
with sulfo-NHS-biotin (Pierce) or OG 488 (Molecular Probes) as per TUNEL materials (Roche Diagnostics) were used as per the manu-
the manufacturer’s directions for labeling protein. Derivatized grB facturer’s instructions. Phosphatidylserine externalization was mea-
was separated from unbound probe by passing the material through sured as previously described (Heibein et al., 1999) using annexin
a Sephadex G-25 column (HiTrap Desalting column, Pharmacia Bio- V-FITC (PharMingen). Percent specific TUNEL/annexin V positive
tech) with saline or phosphate-buffered saline (PBS) as the buffer. cells was calculated as: [(% positive labeling cells with grB and
Typically the concentration of unlabeled grB was z50 mg/ml, AD 2 % positive labeling cells without grB and AD)/(100 2 % positive
whereas the estimated concentration of derivatized material was labeling cells without grB and AD)] 3 100.
z5 mg/ml. GrB was assayed for enzymatic activity using an ASPase
assay as previously described (Caputo et al., 1993). In Vivo Killing Assays
The 51Cr- (lysis) and 3H-thymidine (DNA fragmentation) release
Flow Cytometric Analysis of Cell Surface MPR Expression assays have been previously described (Darmon et al., 1996). Target
Cells (2 3 105) were incubated for 20 min at 48C with a 200-fold cells (1 3 104 cells/well for the 51Cr-release assay and 5 3 104 cells/
dilution of rabbit anti-CI- or CD-MPR and washed. Cells were then well for the 3H-thymidine-release assay) were incubated with CTL
incubated with a 200-fold dilution of goat-anti-rabbit-FITC, washed, at various E:T ratios in the presence or absence of blocking murine-
and analyzed with a Becton Dickenson FACScan equipped with (1 mg/ml) or human- (200 ng/ml) anti-Fas mAb. Data from one experi-
CELLQuest software. PBS/0.1% BSA buffer was used throughout ment represent the mean of data from triplicate samples. Typically,
the procedure. For all flow cytometric analysis, over 10,000 events spontaneous 51Cr-release and DNA fragmentation was less than
(typically 15,000) were recorded. Results are presented as the rela- 10% and 5%, respectively. Percent specific lysis and DNA fragmen-
tive mean fluorescence intensity (MFI), which represents the MFI of tation was calculated as: [(sample cpm – spontaneous cpm)/(total
the population labeled with anti-MPR antisera and secondary Ab cpm – spontaneous cpm)] 3 100.
minus the MFI obtained with secondary Ab treatment alone.
Transplantation and Graft Characterization
MPR– or CI-MPR1 cells were transplanted under the left kidneyGrB Binding Assay
Cells (1–2 3 105) were washed twice and resuspended in buffer capsule of anesthetized SCID-beige or BALB/c mice. Aliquots con-
sisting of 2 3 106 cells were aspirated into polyethylene tubing,before the addition of grB-biotin or -OG in a final volume of 20 ml
for a 30–60 min incubation and washed again twice. In the case of pelleted, and gently placed under the kidney capsule with the aid
of a micromanipulator syringe. Once the tubing was removed, thegrB-biotin, cells were then incubated with streptavidin-cychrome
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capsulotomy was cauterized. At 7- and 14-days post-transplanta- coprotein D acquires mannose 6-phosphate residues and binds to
mannose 6-phosphate receptors. J. Biol. Chem. 269, 17067–17074.tion, grafts were excised from surrounding kidney tissue, embed-
ded, and stored at 2808C. Frozen 5 mm tissue sections were fixed Caputo, A., Garner, R.S., Winkler, U., Hudig, D., and Bleackley, R.C.
with acetone and stained for 30 min with the H-2k-specific mAb (1993). Activation of recombinant cytotoxic cell proteinase-1 re-
11–4.1 or with CD4- or CD8-specific mAb. After labeling with the quires deletion of an amino-terminal dipeptide. J. Biol. Chem. 268,
appropriate secondary biotinylated Ab, an avidin-biotin complex/ 17672–17675.
horseradish peroxidase method was used and developed with 3,3-
Caputo, A., Parrish, J.C., James, M.N.G., Powers, J.C., and
diaminobenzidinetetrahydrochloride. Positive controls included fro-
Bleackley, R.C. (1999). Electrostatic reversal of serine proteinase
zen sections of CBAJ mouse liver for H-2k detection and BALB/c
substrate specificity. Prot. Struct. Funct. Genet. 35, 415–424.
mouse spleens for CD4 and CD8 detection. Negative controls, which
Chappell, S.A., Walsh, T., Walker, R.A., and Shaw, J.A. (1997). Lossresulted in negative staining consisted of omission of the primary
of heterozygosity at the mannose 6-phosphate insulin-like growthmAb. The experiments were conducted such that the identity of the
factor 2 receptor gene correlates with poor differentiation in earlydonor cells was coded and only revealed after all data had been
breast carcinomas. Brit. J. Cancer 76, 1558–1561.analyzed.
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